Immunological aspects of acute kidney injury in patients with liver cirrhosis

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Liver cirrhosis (LC) is often complicated by acute kidney injury (AKI), which is associated with high mortality.

The aimto study the characteristics of the T- and B-immune systems in patients with LC complicated by AKI.

Material and methodsThe study included a cohort of patients hospitalized for AKI that developed secondary to acute decompensation of liver cirrhosis. The comparison group consisted of patients with no renal dysfunction. Immunological testing included determination of the number of T lymphocytes, T helper/inducer cells, cytotoxic T lymphocytes, T lymphocytes expressing activation markers (HLA-DR antigen and interleukin 2 receptor), B lymphocytes, levels of IgM, IgG, IgA, circulating immune complexes (CIC), rheumatoid factor and antibodies to thyroid peroxidase (anti-TPO).

ResultsIn patients with AKI, an increase of IgG, IgA and CIC levels was observed comparatively to the group of healthy individuals. Patients of the compared group without AKI, had increased indexes of B cells, IgG, IgA, IgM and CIC. Patients with AKI had significantly higher levels of IgA, CIC, and anti-TPO, but lower IgM values relatively to the comparison group. As concerning T-system of immunity, an increase of the amount of T helper cells, activated cells and the value of the immunoregulatory index was fixed in the group of patients with the absence of AKI, in comparison with the group of healthy participants, while among patients with AKI only one index was increased – the level cytotoxic T lymphocytes in addition to immunoregulatory index decrease.

Conclusion. In contrast to the group of patients with cirrhosis without AKI, patients with such kind of complication showed a decrease in the immunoregulatory index in the presence of an increase in cytotoxic T cells and the absence of an increase in the number of activated T cells. Differences in humoral component of the immune response in patients with AKI were manifested in the absence of an increase in B-cells number and IgM level with a significant increase in levels of IgA, CIC and anti-TPO.

全文:

受限制的访问

作者简介

Luiza Karzakova

I.N. Ulyanov Chuvash State University of the Ministry of Education and Science of Russia
Cheboksary

编辑信件的主要联系方式.
Email: luizak58@mail.ru
ORCID iD: 0000-0002-5899-6352

MD, Dr. Sci. (Medicine), head of the Department of internal diseases

俄罗斯联邦, 428015, Cheboksary, 15 Moskovsky Avenue

Antonina Ivanova

I.N. Ulyanov Chuvash State University of the Ministry of Education and Science of Russia
Cheboksary

Email: ial.antonina@yandex.ru
ORCID iD: 0000-0003-2054-7591

MD, assistant at the Department of hospital therapy

俄罗斯联邦, 428015, Cheboksary, 15 Moskovsky Avenue

Ildar Abyzov

I.N. Ulyanov Chuvash State University of the Ministry of Education and Science of Russia
Cheboksary

Email: ildarabyzov@gmail.com

MD, assistant at the Department of general surgery and oncology

俄罗斯联邦, 428015, Cheboksary, 15 Moskovsky Avenue

Ivan Sidorov

I.N. Ulyanov Chuvash State University of the Ministry of Education and Science of Russia
Cheboksary

Email: ivansv68@yandex.ru
ORCID iD: 0000-0003-3658-6579

MD, Dr. Sci. (Medicine) professor of the Department of internal diseases

俄罗斯联邦, 428015, Cheboksary, 15 Moskovsky Avenue

Larisa Tarasova

I.N. Ulyanov Chuvash State University of the Ministry of Education and Science of Russia
Cheboksary

Email: tlarisagast18@mail.ru
ORCID iD: 0000-0003-1496-0689

MD, Dr. Sci. (Medicine), head of the Department of hospital therapy

俄罗斯联邦, 428015, Cheboksary, 15 Moskovsky Avenue

Anastasia Odintsova

I.N. Ulyanov Chuvash State University of the Ministry of Education and Science of Russia
Cheboksary

Email: anastasia.od.99@mail.ru
ORCID iD: 0000-0001-7069-5029

resident of the Department of pediatrics and pediatric surgery

俄罗斯联邦, 428015, Cheboksary, 15 Moskovsky Avenue

参考

  1. Карзакова Л.М., Иванова А.Л., Кудряшов С.И. с соавт. Роль дисфункции почек в летальных исходах при циррозе печени. Вестник современной клинической медицины. 2023; 16(2): 23–33. [Karzakova L.M., Ivanova A.L., Kudryashov S.I. et al. The role of renal dysfunction in the fatal outcomes in liver cirrhosis. Vestnik sovremennoy klinicheskoy meditsiny = The Bulletin of Contemporary Clinical Medicine. 2023; 16(2): 23–33 (In Russ.)].https://doi.org/10.20969/VSK M.2023.16(2).23-33. EDN: OJZVDU.
  2. Choi Y.J., Kim Y.J., Koo J.K. et al. Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol. 2014; 20(2): 185–91.https://doi.org/10.3350/cmh.2014.20.2.185. PMID: 25032185. PMCID: PMC4099334.
  3. Tariq R., Hadi Y., Chahal K. et al. Incidence, mortality and predictors of acute kidney injury in patients with cirrhosis: A systematic review and meta-analysis. J Clin Transl Hepatol. 2020; 8(2): 135–42.https://doi.org/10.14218/JCTH.2019.00060. PMID: 32832393. PMCID: PMC7438348.
  4. Desai A.P., Knapp S.M., Orman E.S. et al. Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis – a US population-based study. J Hepatol. 2020; 73(5): 1092–99.https://doi.org/10.1016/j.jhep.2020.04.043. PMID: 32387698. PMCID: PMC7994029.
  5. European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018; 69(2): 406–60. https://doi.org/10.1016/j.jhep.2018.03.024. PMID: 29653741.
  6. Карзакова Л.М., Кудряшов С.И., Луткова Т.С. с соавт. Основы общей иммунологии. Учебное пособие. Чебоксары: Чувашский государственный университет имени И.Н. Ульянова (Чебоксары). 2020: 200. [Karzakova L.M., Kudryashov S.I., Lutkova T.S. et al. Fundamentals of general immunology. Textbook. Cheboksary: I.N. Ulyanov Chuvash State University (Cheboksary). 2020: 200 pp. (In Russ.)]. ISBN: 978-5-7677-3241-8. EDN: VCGKUR.
  7. Safadi R., Ohta M., Alvarez C.E. et al. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology. 2004; 127(3): 870–82. https://doi.org/10.1053/j.gastro.2004.04.062. PMID: 15362042.
  8. Albillos A., Lario M., Alvarez-Mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. J Hepatol. 2014; 61(6): 1385–96. https://doi.org/10.1016/j.jhep.2014.08.010. PMID: 25135860.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2024
##common.cookie##